Ordering molecular genetic tests and reporting results - Practices in laboratory and clinical settings
Ordering molecular genetic tests and reporting results - Practices in laboratory and clinical settings
复制标题
DOI:
10.2353/jmoldx.2008.080050
复制
发表时间:
2008-09-01
影响因子:
4.1
通讯作者:
McGovern, Margaret M.
中科院分区:
文献类型:
--
作者:
Lubin, Ira M.;Caggana, Michele;McGovern, Margaret M.
Previous studies have suggested that patient care may be compromised as a consequence of poor communication between clinicians and laboratory professionals in cases in which molecular genetic test results are reported. To understand better the contributing factors to such compromised care, we investigated both pre- and postanalytical processes using cystic fibrosis mutation analysis as our model. We found that although the majority of test requisition forms requested patient/family information that was necessary for the proper interpretation of test results, in many cases, these data were not provided by die individuals filling out the forms. We found instances in which result reports for simulated diagnostic testing described individuals as carriers where only a single mutation was found with no comment pertaining to a diagnosis of cystic fibrosis. Similarly, reports based on simulated scenarios for carrier testing were problematic when no mutations were identified, and the patient's race/ethnicity and family history were not discussed in reference to residual risk of disease. Remarkably, a pilot survey of obstetrician-gynecologists revealed that office staff, including secretaries, often helped order genetic tests and reported test results to patients, raising questions about what efforts are undertaken to ensure personnel competency. These findings are reviewed in fight of what efforts should be taken to improve die quality of test-ordering and result reporting practices.